BMS Stands Down

January 2004
Multinational Monitor;Jan/Feb2004, Vol. 25 Issue 1/2, p4
Reports on the decision of Bristol-Myers Squibb company to abandon a lawsuit filed by AIDS activists in Thailand against its patent on an AIDS drug in 2004. Argument raised by the activists; Reason behind the company's move.


Related Articles

  • Access for All.  // Pharmaceutical Executive;May2001, Vol. 21 Issue 5, p130 

    Reports on the lawsuits filed by the Prescription Access Litigation Project against Bristol-Myers Squibb over the patent of its drug BuSpar. Allegations of the group; Sales of BuSpar; Members of the group.

  • PATENTS.  // International Law Update;Jun2005, Vol. 11, p88 

    This article focuses on the U.S. lawsuit Bristol-Myers Squibb Co. v. Canada. In the patent action by U.S. drug company, Supreme Court of Canada decides whether to allow appeal of Canadian drug company from order issued under recent patent regulations imposing freeze period on defendant's new...

  • BMS and Ivax Battle In Taxol Litigation.  // Chemical Market Reporter;04/17/2000, Vol. 257 Issue 16, p19 

    Reports the defeat of Bristol-Myers Squibb Co. on the initial round of its lawsuit efforts to block a generic version of its anti-cancer drug Taxol (paclitaxel). Information on the drug; Details on its appeal; Brief background on the lawsuit filed against Ivax Corp.

  • California's statute of limitations applies to breast implant cases: Court. Wojcik, Joanne // Business Insurance;3/20/95, Vol. 29 Issue 12, p65 

    Reports on a California state appellate court ruling that California's one year statute of limitations on medical product liability suits applied to breast implant surgeries. Lawsuit filed by Carol Jo Jones against Bristol-Myers Squibb.

  • LSC files judicial complaint against Bristol-Myers.  // Brandweek;02/09/98, Vol. 39 Issue 6, p56 

    Reports about the complaint filed by Laboratory Skin Care (LSC), manufacturer of LSC Microbial Moisturizer, against Bristol-Myers Squibb. Allegations by LSC against Bristol-Myers.

  • Landmark Thai patents case settles.  // HIV Australia;Mar-May2004, Vol. 3 Issue 3, p38 

    Reports on the settlement of a patent case between Bristol Myers Squibb, the Thai Network of People Living with HIV/AIDS, the AIDS Access Foundation and the Foundation for Consumers in Thailand in 2004. Background on the case; Views of Thongchai Thavichachart, director of the Thai Government...

  • Patent Politics. Sellers, L.J. // Pharmaceutical Executive;Oct2000, Vol. 20 Issue 10, p178 

    Comments on the growing confusion generated by the long legal battle over the patent of the chemical compound paclitaxel. Details on the infringement lawsuit filed by Bristol-Myers Squibb against Ivax; Information on an investigation launched by the Federal Trade Commission; Effect of the case...

  • Former Employee of Bristol-Myers Pleads Guilty to Theft of Trade Secrets.  // Biomedical Market Newsletter;12/15/2010, p1 

    The article discusses a court case wherein defendant Shalin Jhaveri pled guilty to the charge of theft of trade secrets from Bristol-Myers Squibb in Syracuse, New York. It notes that Jhaveri has planned to steal the trade secrets for his own use and transfer them to an individual not connected...

  • Repligen and Bristol-Myers Squibb settle Orencia lawsuit.  // PharmaWatch: Biotechnology;May2008, Vol. 7 Issue 5, p18 

    The article reports on the settlement between Repligen and Bristol-Myers Squibb Co. in its lawsuit alleging infringement of a U.S. patent based on Bristol-Myers Squibb's sale of Orencia for the treatment of rheumatoid arthritis. The settlement provides for Bristol-Myers Squibb to make an initial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics